Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Galit
Galit Avior, Cesarea IL
| Patent application number | Description | Published |
|---|---|---|
| 20100174366 | EUSTACHIAN TUBE DEVICE - The present invention provides a device stenting the ET. The stent (device) provides enhanced ventilation and drainage to the middle ear. Also provided is a method for inserting the device into the Eustachian tube and through the isthmus of a human subject. | 07-08-2010 |
Galit Denkberg, Nofit IL
| Patent application number | Description | Published |
|---|---|---|
| 20100062001 | Antibodies for selective apoptosis of cells - A recombinant isolated antibody and a pharmaceutical composition containing same, capable of specifically recognizing an MHC-peptide complex with an affinity in a nanomolar range and of inducing apoptosis in cancer or pathogen infected cells is provided. Also provided are method for treating and diagnosing cancer or pathogen infection in a subject using the recombinant isolated antibody of the present invention. | 03-11-2010 |
| 20100158927 | ANTIBODIES, METHODS AND KITS FOR DIAGNOSING AND TREATING MELANOMA - A method of diagnosing melanoma and antibodies capable of same are disclosed. The method comprises contacting a cell of the subject with an antibody comprising an antigen recognition domain capable of binding to an MHC-I molecule being complexed with a tyrosinase peptide, wherein the antibody does not bind the MHC-I in the absence of the complexed peptide, and wherein the antibody does not bind the peptide in an absence of the MHC, under conditions which allow immunocomplex formation, wherein a presence of the immunocomplex or level thereof is indicative of the melanoma. Methods for treating melanoma and antibodies capable of same are also disclosed. Pharmaceutical compositions comprising antibodies are also disclosed. | 06-24-2010 |
Galit Efron-Nitzan, Herzliya IL
| Patent application number | Description | Published |
|---|---|---|
| 20100192201 | Method and Apparatus for Excessive Access Rate Detection - A system and method for protection of Web based applications are described. Anomalous traffic can be identified by comparing the traffic to a profile of acceptable user traffic when interacting with the application. Excessive access rates are one type of anomalous traffic that is detected by monitoring a source and determining whether the number of requests that the source generates within a specific time frame is above a threshold. The anomalous traffic, or security events, identified at the individual computer networks are communicated to a central security manager. The central security manager correlates the security events at the individual computer networks to determine if there is an enterprise wide security threat. The central security manager can then communicate instructions to the individual computer networks so as to provide an enterprise wide solution to the threat. Various responsive actions may be taken in response to detection of an excessive access rate. | 07-29-2010 |
| 20100235918 | Method and Apparatus for Phishing and Leeching Vulnerability Detection - A system and method for protection of Web based applications are described. Anomalous traffic can be identified by comparing the traffic to a profile of acceptable user traffic when interacting with the application. Phishing and leeching are one type of anomalous traffic that is detected. The anomalous traffic, or security events, identified at the individual computer networks are communicated to a central security manager. Various responsive actions may be taken in response to detection of phishing or leeching. | 09-16-2010 |
Galit Levitin, Atlanta, GA US
| Patent application number | Description | Published |
|---|---|---|
| 20110275220 | LOW TEMPERATURE METAL ETCHING AND PATTERNING - The present invention is directed to a method and apparatus for etching various metals that may be used in semiconductor or integrated circuit processing through the use of non-halogen gases such as hydrogen, helium, or combinations of hydrogen and helium with other gases such as argon. In one exemplary embodiment of the present invention, in a reaction chamber, a substrate having a metal interconnect layer deposited thereon is exposed to a plasma formed of non-halogen gas. The plasma generated is maintained for a certain period of time to provide for a desired or expected etching of the metal. In some embodiments, the metal interconnect layer may be copper, gold or silver. | 11-10-2011 |
Galit Mazooz, Rehovot IL
| Patent application number | Description | Published |
|---|---|---|
| 20110150976 | TRANSDERMAL DELIVERY OF OLIGOSACCHARIDES - The present invention relates to a system for facilitating transdermal delivery of oligosaccharides, The system includes an apparatus that generates micro-channels in the skin of a subject and a skin patch. The patch includes a pharmaceutical composition containing an active agent of an oligosaccharide. Particularly, the oligosaccharide has 5 to 20 monosaccharide units, such as a pentasaccharide, which exerts anticoagulant activity. The system is capable of delivering the oligosaccharides into the blood circulation for treating thromboembolic diseases. | 06-23-2011 |
Galit Meshulam-Simon, Los Altos, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090176210 | MICROBIAL REDUCTIVE DEHALOGENATION OF VINYL CHLORIDE - Compositions and methods are provided that relate to the bioremediation of chlorinated ethenes, particularly the bioremediation of vinyl chloride by | 07-09-2009 |
Galit Shaltiel, Omer Is
| Patent application number | Description | Published |
|---|---|---|
| 20100048721 | USE OF 2,2,3,3, TETRAMETHYLCYCLOPROPANE CARBOXYLIC ACID DERIVATIVES FOR TREATING PSYCHIATRIC DISORDERS - The invention relates to the use of 2,2,3,3 tetramethylcyclopropane carboxylic acid derivative compounds for the preparation of a medicament for treating a psychiatric disorder preferably a bipolar disorder. The invention additionally relates to the use of the compounds for the preparation of an inhibitor of MIP synthase and to a pharmaceutical composition comprising the compounds for treating a psychiatric disorder. A method for treating a psychiatric disorder preferably a bipolar disorder and a method for inhibiting an enzyme having MIP synthase activity is provided. | 02-25-2010 |
Galit Shustak, Jerusalem IL
| Patent application number | Description | Published |
|---|---|---|
| 20090232867 | Modified conductive surfaces having active substances attached thereto - Novel processes for coating metal surfaces and/or for attaching active substances to metal surfaces, objects having coated metal surfaces and/or active substances attached thereto and uses thereof in the preparation of implantable devices are disclosed. | 09-17-2009 |